TES-1025
CAS No. 1883602-21-8
TES-1025 ( —— )
产品货号. M26841 CAS No. 1883602-21-8
TES-1025 is an effective and selective inhibitor of human α-amino-β-carboxymuconate-ε-semialdehyde decarboxylase (IC50: 13 nM).
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥470 | 有现货 |
|
10MG | ¥640 | 有现货 |
|
25MG | ¥988 | 有现货 |
|
50MG | ¥1409 | 有现货 |
|
100MG | ¥2057 | 有现货 |
|
200MG | 获取报价 | 有现货 |
|
500MG | 获取报价 | 有现货 |
|
1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称TES-1025
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述TES-1025 is an effective and selective inhibitor of human α-amino-β-carboxymuconate-ε-semialdehyde decarboxylase (IC50: 13 nM).
-
产品描述TES-1025 is an effective and selective inhibitor of human α-amino-β-carboxymuconate-ε-semialdehyde decarboxylase (IC50: 13 nM).(In Vitro):TES-1025 increases NAD+ levels in cellular systems.(In Vivo):TES-1025 (0.5 mg/kg; i.v.) shows low blood clearance, with low volumes of distribution and half-lives of about 5.33 h, although the blood concentration of TES-1025 (5 mg/kg) is quantifiable for up to 8 h after oral administration. A good systemic exposure is recorded for TES-1025, with a Cmax of 2570 ng/mL reaches at 2 h. The greater oral exposure of TES-1025 is AUC0-8h of 19?200 h?ng/mL and 36?600 h?ng/mL, respectively.
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体SGLT2
-
研究领域——
-
适应症——
化学信息
-
CAS Number1883602-21-8
-
分子量383.4
-
分子式C18H13N3O3S2
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESOC(=O)Cc1cccc(CSc2nc(-c3cccs3)c(C#N)c(=O)[nH]2)c1
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Global Diabetes Pipeline Landscape Report 2020 Featuring Daewoong's Enavogliflozin & Janssen Biotech's Golimumab Among Others - ResearchAndMarkets.com
产品手册
关联产品
-
G3-C12 TFA (848301-9...
G3-C12 TFA Salt is a specific galectin-3 binding peptide with Ksubdsub of 88 nM and shows anticancer activity.
-
N-Aminopiperidine hy...
Used as organic synthesis and medicine intermediate.
-
Broussonin B
Broussonins A and B, new phytoalexins from diseased paper mulberry.